BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17605872)

  • 1. [Induction of anti-lymphoma cytotoxic T cell effect by dendritic cells transfected with recombinant adenovirus vectors carrying survivin gene].
    Zhu XP; Chen ZZ; Hu JD; Li CT; Yang T; Xu ZS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):591-3. PubMed ID: 17605872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro inducing effect of dendritic cells cotransfected with survivin and granulocyte-macrophage colony-stimulating factor on cytotoxic T cell to kill leukemic cells.
    Zhu XP; Chen ZZ; Li CT; Lin X; Zhuang JL; Hu JD; Yang T; Xu ZS
    Chin Med J (Engl); 2008 Nov; 121(21):2180-4. PubMed ID: 19080181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-prostate cancer effects of CTL cell induction in vitro by recombinant adenovirus mediated PSMA/4-1BBL dendritic cells: an immunotherapy study.
    Sui CG; Wu D; Meng FD; Yang MH; Jiang YH
    Genet Mol Res; 2015 Jun; 14(2):7208-17. PubMed ID: 26125931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in immune function of dendritic cells infected by recombinant adenovirus containing Her2/neu gene of extracellular and transmembrane domain proteins].
    Ma SD; Luo RC; Ding ZH; Lu F; Yuan CQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1184-7. PubMed ID: 16939917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effect of dendritic cells transfected with prostate-specific membrane antigen recombinant adenovirus on prostate cancer: An in vitro study.
    Meng FD; Wang S; Jiang YH; Sui CG
    Mol Med Rep; 2016 Mar; 13(3):2124-34. PubMed ID: 26783185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of expression vector of hTERT- hIL18 fusion gene and induction of cytotoxic T lymphocyte response against hTERT.
    Tong XM; Zheng SE; Bader A; Yao HP; Wu NP; Altmeyer P; Brockmeyer NH; Jin J
    Eur J Med Res; 2008 Jan; 13(1):7-14. PubMed ID: 18226991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of immunological effect of dendritic cell transfected with survivin gene on the specific anti-alimentary tract tumor].
    Sun HW; Tang C; Tang QB; Zou SQ; Qiu FZ
    Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(5):313-6. PubMed ID: 15842941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Construction of recombinant adenovirus vector containing human survivin gene and its expression in dendritic cells].
    Zhu XP; Chen ZZ; Lin X; Hu JD; Li CT; Yang T; Xu ZS; Lü LL; Chen CP; Zhang LH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):791-4. PubMed ID: 16928323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-tumor immune response of dendritic cells derived from lymphoma cells transduced with recombinant adenovirus encoding human P53].
    Liu ZF; Tang H; Song FX; Zeng PY; Yue LL; Zhang LS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):592-7. PubMed ID: 22739162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells.
    Schmidt SM; Schag K; Müller MR; Weck MM; Appel S; Kanz L; Grünebach F; Brossart P
    Blood; 2003 Jul; 102(2):571-6. PubMed ID: 12576330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro induction of specific anti-tumoral immunity against laryngeal carcinoma by using human interleukin-12 gene-transfected dendritic cells.
    Liang W; Wang XF
    Chin Med J (Engl); 2011 May; 124(9):1357-61. PubMed ID: 21740748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro anti-tumor immune response induced by dendritic cells transfected with recombinant adenovirus carrying mutant K-ras genes.
    Zhao F; Zhou Q; Lu Y; Qin Y; Zhang J; Li J; Wang J
    J Huazhong Univ Sci Technolog Med Sci; 2005; 25(4):378-81. PubMed ID: 16196281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient generation of survivin-specific cytotoxic T lymphocytes from healthy persons in vitro: quantitative and qualitative effects of CD4+ T cells.
    Kim EK; Cho HI; Yoon SH; Park MJ; Sohn HJ; Kim HJ; Oh ST; Kim TG
    Vaccine; 2008 Jul; 26(32):3987-97. PubMed ID: 18584926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells with transduced survivin gene induce specific cytotoxic T lymphocytes in human urologic cancer cell lines.
    Kikkawa K; Fujii R; Kuramoto T; Mori T; Inagaki T; Kohjimoto Y; Iwahashi M; Yamaue H; Hara I
    Urology; 2009 Jul; 74(1):222-8. PubMed ID: 19285711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [GM-CSF gene-modified dendritic cell vaccine enhances antitumor immunity in vitro].
    He SB; Sun K; Wang L; Li DC; Zhang YY
    Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):410-4. PubMed ID: 20819479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant mammaglobin A adenovirus-infected dendritic cells induce mammaglobin A-specific CD8+ cytotoxic T lymphocytes against breast cancer cells in vitro.
    Cui H; Zhang W; Hu W; Liu K; Wang T; Ma N; Liu X; Liu Y; Jiang Y
    PLoS One; 2013; 8(5):e63055. PubMed ID: 23650543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SLC gene-modified dendritic cells mediate T cell-dependent anti-gastric cancer immune responses in vitro.
    Xue G; Cheng Y; Ran F; Li X; Huang T; Yang Y; Zhang Y
    Oncol Rep; 2013 Feb; 29(2):595-604. PubMed ID: 23229068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Construction of genetically modified dendritic cell vaccine expressing bcr/abl fusion gene and inducing specific cytotoxic T lymphocytes to kill K562 cells in vitro].
    Wang WW; Huang RW; Hu Y; Li XD; Wang DN; He Y; Liu JJ
    Ai Zheng; 2009 Jun; 28(6):602-6. PubMed ID: 19635197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of human dendritic cells by recombinant modified vaccinia virus Ankara vectors encoding survivin and IL-2 genes in vitro.
    Tao R; Li L; Huang W; Zheng L
    Hum Gene Ther; 2010 Jan; 21(1):98-108. PubMed ID: 19715401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immune response of HBsAg gene-modified dendritic cell-based vaccine in HepG2. 2. 15 hepatocellular carcinoma cells].
    Yang JY; Liu WC; Cao DY; Si XM; Teng ZH
    Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):728-32. PubMed ID: 18396682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.